General
Showing 305–320 of 1342 results
-
Article: ESMO develops new, living guidelines for the treatment of patients with metastatic non-small cell lung cancer
€3.03 Add to cart -
Article: ESMO NET (Neuroendocrine Tumours) Report 2024: Two breakthrough studies changing the future treatment algorithm of NET
€3.03 Add to cart -
Article: ESOU22: Updates on GU cancers and meeting highlights
€3.03 Add to cart -
Article: Ethnic Paradigm in Prostate Cancer – does it really matter?
€3.03 Add to cart -
Article: European Commission approves talazoparib plus enzalutamide for the treatment of metastatic castrationresistant prostate cancer
€3.03 Add to cart -
Article: European Commission approves talazoparib plus enzalutamide for the treatment of metastatic castrationresistant prostate cancer
€3.03 Add to cart -
Article: European Society for Medical Oncology (ESMO) 2012
€3.03 Add to cart -
Article: Evans blue as a diagnostic tool for non-muscle-invasive bladder cancer: a preclinical study
€3.03 Add to cart -
Article: Everolimus delays disease progression in patients with advanced lung and gastrointestinal neuroendocrine tumors
€3.03 Add to cart -
Article: Exchange of data between a Comprehensive Cancer Centre and the Belgian Cancer Registry: a single university institution experience
€3.03 Add to cart -
Article: Exploiting genomic vulnerabilities in lung cancer for therapeutic targeting
€3.03 Add to cart -
Article: Exploration of quorum sensing peptides: the missing link between microbiome and cancer outcome?
€3.03 Add to cart -
Article: Exploring extracellular vesicles for siRNA delivery and Raman-based diagnostics
€3.03 Add to cart -
Article: Extended adjuvant endocrine therapy: the impact of recent insights on clinical practice
€3.03 Add to cart -
Article: Extended front-line bevacizumab treatment associated with favourable outcome in ovarian cancer
€3.03 Add to cart -
Article: Extensive-stage small cell lung cancer: evolving therapeutic strategies
€3.03 Add to cart